imidazolone and Multiple-Sclerosis--Relapsing-Remitting

imidazolone has been researched along with Multiple-Sclerosis--Relapsing-Remitting* in 1 studies

Other Studies

1 other study(ies) available for imidazolone and Multiple-Sclerosis--Relapsing-Remitting

Article	Year
Advanced glycation end products contribute to the immunogenicity of IFN-β pharmaceuticals. The Journal of allergy and clinical immunology, 2012, Volume: 129, Issue:3 Topics: Adult; Animals; Antibodies, Neutralizing; CHO Cells; Cricetinae; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Female; Glycation End Products, Advanced; Glycosylation; Haptens; Humans; Imidazoles; Immunotherapy; Interferon-beta; Lysine; Male; Multiple Sclerosis, Relapsing-Remitting; Protein Processing, Post-Translational; Recombinant Proteins	2012

Article

Year

Advanced glycation end products contribute to the immunogenicity of IFN-β pharmaceuticals.

The Journal of allergy and clinical immunology, 2012, Volume: 129, Issue:3

Topics: Adult; Animals; Antibodies, Neutralizing; CHO Cells; Cricetinae; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Female; Glycation End Products, Advanced; Glycosylation; Haptens; Humans; Imidazoles; Immunotherapy; Interferon-beta; Lysine; Male; Multiple Sclerosis, Relapsing-Remitting; Protein Processing, Post-Translational; Recombinant Proteins

2012